Picture of Integral Ad Science Holding logo

IAS Integral Ad Science Holding News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer CyclicalsAdventurousMid CapSuper Stock

Integral Ad Science Q3 revenue beats estimates

Overview

IAS Q3 revenue grows 16% yr/yr to $154.4 mln, beating analyst expectations

Adjusted EBITDA for Q3 beats estimates, increasing to $55.3 mln

IAS in process of being bought by acquisition PE firm Novacap

Outlook

IAS will not provide a financial outlook due to pending acquisition by Novacap

Result Drivers

OPTIMIZATION REVENUE - Optimization revenue increased 21% to $73.7 mln, contributing significantly to overall revenue growth

PUBLISHER REVENUE - Publisher revenue rose 21% to $23.5 mln, supporting overall revenue increase

MEASUREMENT REVENUE - Measurement revenue grew 8% to $57.1 mln, adding to total revenue growth

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueBeat$154.35 mln$149.22 mln (14 Analysts)
Q3 Net Income$7.04 mln
Q3 Adjusted EBITDABeat$55.30 mln$52.23 mln (13 Analysts)
Q3 Gross Margin77%
Q3 Basic EPS$0.04
Q3 Operating Income$7.57 mln
Q3 Pretax Profit$8.16 mln
Analyst Coverage The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 13 "hold" and no "sell" or "strong sell" The average consensus recommendation for the advertising & marketing peer group is "buy." Wall Street's median 12-month price target for Integral Ad Science Holding Corp is $10.30, about 0.8% above its November 3 closing price of $10.22 The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 25 three months ago Press Release: ID:nPn5wZSgba For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Integral Ad Science Holding

See all news